Solution Building: Merck Avoids One-Size-Fits-All Approach to AI and ML – Genetic Engineering and Biotechnology News
Iya Khalil, PhD, discusses the pharma giant’s leveraging of artificial intelligence and machine learning with GEN Edge By Alex Philippidis Addressing the Goldman Sachs Healthcare C-Suite Unscripted Conference last year, Merck & Co. Chairman and CEO Robert A. Davis told investors the pharma giant was spending undisclosed “significant” capital toward automating processes, analyzing data, and […]